Pharmacists must be experts on follow-on biologics (FOBs), including biosimilars, so they can provide education to health professionals about safe prescribing and use, which ultimately affects patient care.
Mark Borns, PharmD
Advertisement
Articles by Mark Borns, PharmD
Pharmacists need to be experts on follow-on biologics, including biosimilars, so they can provide education to health professionals about safe prescribing and use.
Health care practitioners need to prepare for myriad questions regarding biosimilars and follow-on biologic drugs as they enter the market.
Advertisement
Latest Updated Articles
Biosimilars and Follow-on Biologics: A Pharmacist OpportunityPublished: November 17th 2016 | Updated:
Biosimilars and Follow-on BiologicsPublished: September 28th 2017 | Updated:
Biosimilars and Follow-on Biologics: A Pharmacist OpportunityPublished: October 12th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Regular Melatonin Supplementation May Hide Hidden Heart Complications
2
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
3
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
4
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
5
